Inhibition of the T-cell receptor signalling pathway for treatment of T-cell lymphoma

Laura B Freeman

Pooled Investigation of Pesticides and Lymphoma and Multiple Myeloma and Immunoproliferative Diseases in NCI and Cross-Canada Case-Control Studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

George Thomas

The Function of rpL5 and rpL11 in Induction of p53

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Christian Steidl

Somatic mutations in the JAK-STAT signaling pathway in primary mediastinal large B cell lymphoma

Non-Hodgkin lymphoma Hodgkin lymphoma

Lynn Goldin

Autoimmune Diseases and Risk for Lymphoma and Other Cancers

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Gregory J Hannon

Cold Spring Harbor Laboratory Cancer Research Center

Trachea, bronchus and lung Pancreas Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Breast

James C Paulson

In vivo Targeting of Hematopoetic Cells With Glycan Ligands of Siglecs

Non-Hodgkin lymphoma Leukaemia

Hematology and hematologic malignancies

Michael Wang

A Phase II, Multicenter, International Study of Lenalidomide and Rituximab in Relapsed/Refractory Mantle Cell Lymphoma, Diffuse Large B-Cell Non-Hodgkin Lymphoma, Transformed Large Cell Lymphoma, and Grade 3 Follicular Lymphoma

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Mary Ellen Conley

Genetic Etiology of Agammaglobulinemia with Absent B Cells

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Robert Yarchoan

Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies

Non-Hodgkin lymphoma Kaposi sarcoma